Search results for "molecular microbiology"
Selected Filters:
Bosch and Randox invest in the Vivalytic analysis platform
Smartphone-sized laboratory – Sepsis IVD grade test based on cutting-edge BioMEMS technology is a joint development objective
How the human microbiome impacts health and disease
This special feature explores the impact of the human microbiome on disease development and highlights the latest innovations driving microbiome research
Thermo Fisher Scientific and 908 Devices Demonstrate Innovative Separation Technology with Industry-Leading Orbitrap Mass Spectrometers at ASMS 2016
New innovative ZipChip microfluidic inlet technology designed for fast MS analysis of biomolecules
Position Your Research - with Breakthrough, Intelligent Imaging Solutions
Resuspension Calculator
Integrated DNA Technologies Inc.The Resuspension Calculator assists in determining the volume needed to resuspend a dry, lyophilized oligo to a desired concentration
New Affordable Advanced NGS Cancer Test Launched by EKF Subsidiary
Selah and GHS partner to pave the way for accessible, low-cost personalized medicine
QIAGEN Reaches Milestone with Portfolio of Master Collaboration Agreements for Pharma Companion Diagnostics
Record number of new projects involves start of new master collaboration with Array BioPharma
Quantitative Image Analysis of Intracellular Protein Dynamics
Meet the reviewers who have hit the jackpot in our giveaways
SelectScience is pleased to congratulate the latest winners of our reviews competitions
Characterizing lipid nanoparticles for drug delivery: Latest advancements and expert opinion
A panel of experts share their insights into the development of lipid nanoparticles for drug delivery and reveal the analytical solutions designed to help labs advance further in this field.
The Future of Precision Medicine: Proteomic Analysis by Mass Spectrometry
Agendia Highlights Study Showing MammaPrint/BluePrint Tests Predict Response to Current Breast Cancer Chemotherapy and Targeted Therapy Regimens
Researchers present data at breast cancer symposium showing MammaPrint/BluePrint can identify women who benefit from chemotherapy and targeted dual anti-HER2 drug treatment before surgery